DMKJ
UTHR icon

David M. Knott Jr’s United Therapeutics UTHR Stock Holding History

David M. Knott Jr’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,949
Closed -$2.02M – 132
2023
Q3 		$2.02M Buy
+8,949
New +$2.06M 0.77% 25
2022
Q2 		– Sell
-3,383
Closed -$607K – 199
2022
Q1 		$607K Hold
3,383
– – 0.19% 74
2021
Q4 		$731K Buy
+3,383
New +$664K 0.25% 59

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

David M. Knott Jr's UTHR Position: Q4 2023 in Review

David M. Knott Jr sold out of United Therapeutics (UTHR) in Q4 2023, closing a stake of 8,949 shares — an estimated $2.02M sold.

David M. Knott Jr first reported a position in UTHR in Q4 2021 and held it in 3 quarters. The position peaked at $2.02M in Q3 2023. 535 funds tracked by Wall St. Rank hold UTHR as of Q4 2023.

  • David M. Knott Jr reported no remaining United Therapeutics position as of Q4 2023 after selling out during the quarter.
  • David M. Knott Jr sold 8,949 United Therapeutics shares in Q4 2023, an estimated $2.02M.
  • David M. Knott Jr first reported a position in United Therapeutics in Q4 2021 and held it in 3 quarters.
  • David M. Knott Jr's United Therapeutics position peaked at $2.02M in Q3 2023.
  • 535 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2023.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.